Fecal Lactoferrin 17.3 µg/g in a 6-Month-Old: Interpretation and Management
A fecal lactoferrin level of 17.3 µg/g in a 6-month-old infant indicates intestinal inflammation and warrants further evaluation to distinguish between infectious enteritis and inflammatory bowel disease, though you must first determine if the infant is breastfed, as lactoferrin is a normal component of human milk that can confound interpretation.
Critical First Step: Feeding History
Before proceeding with any diagnostic workup, determine if the infant is breastfed. The 2017 IDSA guidelines explicitly state that "lactoferrin is a normal component of human milk and therefore may be present in varying amounts in stools of infants who consume human milk, making assay results difficult to interpret in these infants" 1. If the infant is exclusively or partially breastfed, this result may be falsely elevated and clinically meaningless.
If NOT Breastfed: Interpretation
The level of 17.3 µg/g is abnormally elevated and indicates intestinal inflammation:
- Normal cutoff: <7.3 µg/g 2
- IBD diagnostic threshold: 13 µg/g (sensitivity 80.7%, specificity 92.7%) 3
- Your patient's value of 17.3 µg/g exceeds both thresholds
This elevation suggests active intestinal inflammation from either:
- Infectious enteritis (bacterial or viral)
- Early inflammatory bowel disease (though rare at 6 months)
- Other inflammatory conditions (e.g., allergic colitis, Henoch-Schönlein purpura)
Diagnostic Algorithm
Immediate Clinical Assessment
Look for these specific features:
For Infectious Enteritis:
- Acute onset (<14 days)
- Fever
- Bloody or mucoid stools
- Recent sick contacts or daycare exposure
- Vomiting
- Dehydration signs
For IBD (rare but possible):
- Chronic symptoms (>4 weeks)
- Poor weight gain or weight loss
- Perianal disease
- Family history of IBD
- Persistent symptoms despite treatment
Laboratory Workup
Stool studies (despite IDSA guidelines stating lactoferrin shouldn't establish infectious cause 1, you still need pathogen identification):
- Bacterial culture (Salmonella, Shigella, Campylobacter, pathogenic E. coli)
- C. difficile testing if recent antibiotics
- Viral PCR panel if available
- Ova and parasites if travel history
Blood work:
- CBC with differential (anemia, thrombocytosis suggest chronicity)
- ESR/CRP (elevated supports inflammation)
- Comprehensive metabolic panel (assess for complications)
- Albumin (low suggests chronic inflammation)
Consider fecal calprotectin if IBD suspected (more specific than lactoferrin for chronic inflammation)
Management Approach
If Acute Presentation (<2 weeks):
Treat as infectious enteritis:
- Supportive care with hydration
- Empiric antibiotics only if:
- Severe illness with high fever
- Bloody diarrhea with systemic toxicity
- Immunocompromised
- Await culture results before continuing antibiotics
- Recheck in 7-10 days; symptoms should resolve
If Chronic Presentation (>4 weeks) or Red Flags:
Refer to pediatric gastroenterology for:
- Upper endoscopy and colonoscopy with biopsies
- Evaluation for early-onset IBD
- Assessment for cow's milk protein allergy
- Rule out other causes of chronic inflammation
Important Caveats
The 2017 IDSA guidelines recommend against using fecal lactoferrin to establish the cause of acute infectious diarrhea 1, but this doesn't mean the result is useless—it confirms inflammation is present, which narrows your differential and guides intensity of workup.
Research shows lactoferrin has 100% sensitivity and 100% negative predictive value for detecting active Crohn's disease in children 4, and levels >60 µg/g have 84% sensitivity for active disease 4. Your patient's level of 17.3 µg/g is elevated but not in the range typically seen with established IBD (which averages 313.6 µg/g for Crohn's and 370.7 µg/g for ulcerative colitis) 2.
Do not dismiss this as normal variation—the specificity of 92.7% at the 13 µg/g cutoff means this represents true pathology 3.